Oct 192015
 

By Talent4Boards Team

Talent4Boards – Great Talent builds Great Boards

– USA, CA – BioTime, Inc. (NYSE and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, reported today that its Board of Directors has appointed Adi Mohanty to serve with Michael D. West, PhD, as co-Chief Executive Officer.… => more

BioTime names its COO Adi Mohanty as Co-CEO

From:: BioTime names its COO Adi Mohanty as Co-CEO

 Posted by at 12:00 pm

Sorry, the comment form is closed at this time.

%d bloggers like this: